Views & Analysis What doctors say about the EU referendum Daniel Ghinn tunes into the conversation around the EU referendum, which takes place on Thursday
Articles Pharma warns of European exit – but British public needs mor... If there is one thing that big pharma companies hate more than anything, it's uncertainty about the future of their markets and regulations.
News Novartis pays $1bn upfront for Huntington's drug from PTC Novartis has made a return to the Huntington's disease stage by licensing an oral mRNA splicer from PTC Therapeutics for $1 billion upfront.
Digital Sponsored The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
